Investors

News Release Details

<< Back

Kosmos Energy Ltd - Director/PDMR Shareholding

02/05/19 07:01 GMT
RNS Number : 0465P
Kosmos Energy Limited
05 February 2019
 

Kosmos Energy Ltd (the "Company")
PDMR Shareholding

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

5 February 2019

The following Persons Discharging Managerial Responsibilities ("PDMRs") have had changes in their shareholdings of Common Shares in the Company:

PDMR

Date of transaction

No. of shares vested

No. of shares granted

No. of shares sold or withheld

Christopher J. Ball

 

 

31 January 2019

0

73,125

0

Thomas P. Chambers

31 January 2019

0

73,125

0

Richard R. Clark

31 January 2019

0

73,125

0

Jason E. Doughty

31 January 2019

0

52,152

0

Eric J. Haas

31 January 2019

0

44,076

0

Andrew G. Inglis

31 January 2019

0

123,825

0

Paul M. Nobel

31 January 2019

0

40,000

0

 

The Notification of Dealing Form for each PDMR, which provides full details of the transactions outlined above, can be found below.

This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.

 

Richard J. Stephens

Assistant Secretary
 


CONTACT:

Investor Relations

Jamie Buckland
+44 203 954 2831
jbuckland@kosmosenergy.com

Rhys Williams
+1-214-445-9693

rwilliams@kosmosenergy.com

Media Relations

Thomas Golembeski
+1-214-445-9674

tgolembeski@kosmosenergy.com

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Christopher J. Ball

b)

Position / status

SVP and Chief Commercial Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

73,125 restricted share units granted under the Company's Long Term Incentive Plan (the "Plan") which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2020, 2021 and 2022, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

(3)   Shares vested

c)

Currency

USD

Price

5.13

Volume

73,125

Total

375,131.25

(4)   Shares sold or withheld

Currency

USD

Price

0.00

Volume

0.00

Total

0.00

d)

Aggregated information 

Price

5.13

Volume

73,125

Total

375,131.25

e)

Date of the transactions

31 January 2019

f)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Thomas P. Chambers

b)

Position / status

Senior Vice President and Chief Financial Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

73,125 restricted share units granted under the Company's Long Term Incentive Plan (the "Plan") which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2020, 2021 and 2022, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

(3)   Shares vested

c)

Currency

USD

Price

5.13

Volume

73,125

Total

375,131.25

(4)   Shares sold or withheld

Currency

USD

Price

0.00

Volume

0.00

Total

0.00

d)

Aggregated information 

Price

5.13

Volume

73,125

Total

375,131.25

e)

Date of the transactions

31 January 2019

f)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Richard R. Clark

b)

Position / status

Senior Vice President and President, Gulf of Mexico

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

73,125 restricted share units granted under the Company's Long Term Incentive Plan (the "Plan") which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2020, 2021 and 2022, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

(3)   Shares vested

c)

Currency

USD

Price

5.13

Volume

73,125

Total

375,131.25

(4)   Shares sold or withheld

Currency

USD

Price

0.00

Volume

0.00

Total

0.00

d)

Aggregated information 

Price

5.13

Volume

73,125

Total

375,131.25

e)

Date of the transactions

31 January 2019

f)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Jason E. Doughty

b)

Position / status

Senior Vice President, General Counsel

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

52,152 restricted share units granted under the Company's Long Term Incentive Plan (the "Plan") which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2020, 2021 and 2022, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

(3)   Shares Vested

c)

Currency

USD

Price

5.13

Volume

52,152

Total

267,539.76

(4)   Shares sold or withheld

Currency

USD

Price

0.00

Volume

0.00

Total

0.00

d)

Aggregated information 

Price

5.13

Volume

52,152

Total

267,539.76

e)

Date of the transactions

31 January 2019

f)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Eric J. Haas

b)

Position / status

Senior Vice President, Production and Development

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

44,076 restricted share units granted under the Company's Long Term Incentive Plan (the "Plan") which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2020, 2021 and 2022, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

(3)   Shares vested

c)

Currency

USD

Price

5.13

Volume

44,076

Total

226,109.88

(4)   Shares sold or withheld

Currency

USD

Price

0.00

Volume

0.00

Total

0.00

d)

Aggregated information 

Price

5.13

Volume

44,076

Total

226,109.88

e)

Date of the transactions

31 January 2019

f)

Place of the transaction

NYSE

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Andrew G. Inglis

b)

Position / status

Chairman and Chief Executive Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

123,825 restricted share units granted under the Company's Long Term Incentive Plan (the "Plan") which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2020, 2021 and 2022, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

(3)   Shares vested

c)

Currency

USD

Price

5.13

Volume

123,825

Total

635,222.25

(4)   Shares sold or withheld

Currency

USD

Price

0.00

Volume

0.00

Total

0.00

d)

Aggregated information 

Price

5.13

Volume

123,825

Total

635,222.25

e)

Date of the transactions

31 January 2019

f)

Place of the transaction

NYSE

 

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Paul M. Nobel

b)

Position / status

Senior Vice President, Chief Accounting Officer

c)

Initial notification / amendment

Initial notification

2.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Common Shares, par value $0.01 per share

b)

Nature of the transactions

40,000 restricted share units granted under the Company's Long Term Incentive Plan (the "Plan") which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2020, 2021 and 2022, subject to the terms of the Plan and the applicable award agreement issued thereunder.

 

(3)   Shares vested

c)

Currency

USD

Price

5.13

Volume

40,000

Total

205,200.00

(4)   Shares sold or withheld

Currency

USD

Price

0.00

Volume

0.00

Total

0.00

d)

Aggregated information 

Price

5.13

Volume

40,000

Total

205,200.00

e)

Date of the transactions

31 January 2019

f)

Place of the transaction

NYSE

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHSSMEDLFUSESE